JAR（人胎盤絨毛癌細(xì)胞）
CBP60728
詢 價
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. General information | |
| Synonyms: | JAR |
| Background: | The JAR line was established by R. A. Pattillo and associates directly from a trophoblastic tumor of the placenta. |
| Species: | Homo sapiens, human |
| Tissue: | placenta |
| Disease: | choriocarcinoma |
| Gender: | fetus, male Caucasian |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| Doubling Time: | N/A |
| DNA Profile: | Amelogenin: X,Y CSF1PO: 7,10 D13S317: 11 D16S539: 9,10 D5S818: 10,11 D7S820: 10,11 THO1: 6,7 TPOX: 8,11 vWA: 16,18 Our Cell Line Authentication Service |
| Culture Medium: |
RPMI 1640+10%FBS JAR完全培養(yǎng)基，# CBP60728M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Genes Expressed: | estrogen; progesterone; human chorionic gonadotropin (hCG); human chorionic somatomammotropin (placental lactogen); hCG production averages 22.5 ng/mL after reculturing |
| Comments: | liquid nitrogen vapor phase For more information, please contact us (4008-750-250). |
